CellUranics Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series A1

  • Investors
  • 8

CellUranics General Information

Description

Manufacturer of bio-based platform compounds intended to facilitate the low-carbon transformation of the chemical industry. The company utilizes proprietary chemical catalysis and continuous production processes to convert renewable feedstocks into glucaric acid and 2,5-furandicarboxylic acid, enabling manufacturers in the packaging, textile, and new energy sectors to replace petroleum-based materials with sustainable, high-performance bio-based alternatives.

Contact Information

Website
celluranics.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Number 18-28, Tongjiang Road, Taixing Economic Development Zone
  • A012
  • Taixing, Jiangsu 225400
  • China
+86 189
Primary Industry
Specialty Chemicals
Vertical(s)
Manufacturing, Climate Tech
Corporate Office
  • Number 18-28, Tongjiang Road, Taixing Economic Development Zone
  • A012
  • Taixing, Jiangsu 225400
  • China
+86 189

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CellUranics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC (Series A1) 11-Oct-2026 Completed Generating Revenue
2. Early Stage VC 21-Sep-2023 Completed Generating Revenue
1. Early Stage VC 14-Jul-2022 Completed Generating Revenue
To view CellUranics’s complete valuation and funding history, request access »

CellUranics Patents

  • 4

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 3

    Pending

  • Expiring in next 12 mo

CellUranics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4477651-A1 Method for preparing 2,5-furandicarboxylic acid compound Pending 10-Mar-2022
EP-4477651-A4 Method for preparing 2,5-furandicarboxylic acid compound Pending 10-Mar-2022
US-20250188048-A1 Method for preparing 2,5-furandicarboxylic acid compound Pending 10-Mar-2022
WO-2023169517-A1 Method for preparing 2,5-furandicarboxylic acid compound Inactive 10-Mar-2022 C07D307/68

CellUranics Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Xiamen Qisheng Venture Capital Corporate Venture Capital Minority
Jinshan Capital Group Venture Capital Minority
Lan Fund Venture Capital Minority
Plug and Play Accelerator/Incubator Minority
Puhua Capital Venture Capital Minority
You’re viewing 5 of 8 investors. Get the full list »

Ready to get started?

Request a free trial

CellUranics FAQs

  • When was CellUranics founded?

    CellUranics was founded in 2020.

  • Where is CellUranics headquartered?

    CellUranics is headquartered in Taixing, China.

  • What industry is CellUranics in?

    CellUranics’s primary industry is Specialty Chemicals.

  • Is CellUranics a private or public company?

    CellUranics is a Private company.

  • What is CellUranics’s current revenue?

    The current revenue for CellUranics is .

  • Who are CellUranics’s investors?

    Xiamen Qisheng Venture Capital, Jinshan Capital Group, Lan Fund, Plug and Play, and Puhua Capital are 5 of 8 investors who have invested in CellUranics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process